Your session is about to expire
← Back to Search
Temporary changes in an already-implanted medical device (biventricular pacemaker) for Left Ventricular Assist Device Infection
N/A
Recruiting
Led By Uma Srivatsa, MD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2-5 minutes
Awards & highlights
Study Summary
This trial is examining whether or not different settings on a pacemaker can affect the function of an LVAD.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2-5 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-5 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
LVAD flow
LVAD power
LVAD pulsatility index (PI)
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: CohortExperimental Treatment1 Intervention
Pacemakers will be programmed to BiV pacing, left ventricular (LV) pacing, right ventricular (RV) pacing and no pacing for five minutes each. LVAD flow will be recorded every thirty seconds for five minutes with each setting. Once the interventions have been completed, all pacemakers will be returned to their original setting.
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
914 Previous Clinical Trials
4,720,681 Total Patients Enrolled
University of California, San DiegoOTHER
1,130 Previous Clinical Trials
1,552,822 Total Patients Enrolled
Uma Srivatsa, MDPrincipal InvestigatorUC Davis
3 Previous Clinical Trials
27 Total Patients Enrolled
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger